Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 11, 2021
Reporting Period: Event-based disclosure regarding upcoming investor meetings.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure of a corporate event rather than a financial statement.
Material Changes
No material financial changes or operational updates are reported in this filing. The document solely announces the company's participation in virtual meetings with analysts and investors.
Guidance, Outlook, and Management Commentary
- Event: Processa will participate in virtual meetings with analysts and investors from January 11, 2021, through January 14, 2021, concluding with the H.C. Wainwright Bioconnect 2021 Conference.
- Materials: A presentation handout (Exhibit 99.2) will be used during these meetings and is available on the company's website.
- Disclosure Policy: The company notes it routinely uses its website to disclose material non-public information under Regulation FD but undertakes no obligation to update the information in this specific report.
Investor Verification Checklist
- Verify the content of the attached "January 2021 Corporate Presentation Handout" (Exhibit 99.2) for specific business updates.
- Confirm the company's website (processapharmaceuticals.com) for the latest investor materials.
- Note that the information in this 8-K is not deemed "filed" for purposes of Section 18 of the Exchange Act.